Seizert Capital Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,370
| Closed | -$327K | – | 204 |
|
|
2022
Q2 | $327K | Hold |
7,370
| – | – | 0.02% | 183 |
|
|
2022
Q1 | $365K | Hold |
7,370
| – | – | 0.02% | 179 |
|
|
2021
Q4 | $375K | Buy |
+7,370
| New | +$375K | 0.02% | 185 |
|
|
2020
Q3 | – | Sell |
-19,848
| Closed | -$952K | – | 221 |
|
|
2020
Q2 | $952K | Sell |
19,848
-3,298
| -14% | -$158K | 0.06% | 116 |
|
|
2020
Q1 | $1.07M | Sell |
23,146
-2,030
| -8% | -$93.4K | 0.08% | 105 |
|
|
2019
Q4 | $1.51M | Buy |
+25,176
| New | +$1.51M | 0.08% | 106 |
|